
Blood-Based Screening for CRC Promising but Lacks Efficacy
Blood-based screening for colorectal cancer (CRC), known as a “liquid biopsy,” may be used for patients who skip traditional screening tests, but cannot replace colonoscopy as the gold standard due to higher rates of false positives and false negatives. Two modeling studies and expert consensus suggest that while blood tests may be more convenient, they…